ViiV Healthcare

ViiV Healthcare announces Juluca (dolutegravir/rilpivirine) maintains HIV viral suppression at 148-weeks
Pharmaceutical Business Review
Thu, 04/4/19 - 11:58 am
ViiV Healthcare
Dolutegravir
rilpivirine
JNJ
Janssen
HIV
Monthly shots control HIV as well as daily pills in two big studies
Stat
Thu, 03/7/19 - 09:21 pm
HIV
AIDS
JNJ
Janssen
ViiV Healthcare
cabotegravir
Edurant
Biktarvy's success raises doubts about ViiV's 'new era' of HIV treatment
Biopharma Dive
Wed, 12/12/18 - 12:07 am
GSK
ViiV Healthcare
HIV
ViiV Healthcare’s HIV-1 drug fostemsavir succeeds in phase 3 trial
Pharmaceutical Business Review
Thu, 11/1/18 - 10:47 am
ViiV Healthcare
HIV
clinical trials
fostemsavir
ViiV Healthcare reports positive results for late-stage HIV trials
Marketwatch
Thu, 06/14/18 - 09:19 am
ViiV Healthcare
GSK
Pfizer
Shionogi
HIV
clinical trials
Dolutegravir
lamivudine
ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
CP Wire
Mon, 05/21/18 - 09:08 am
ViiV Healthcare
Juluca
Europe
HIV
ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV
Mon, 05/21/18 - 08:31 am
ViiV Healthcare
HIV
Juluca
ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment
Yahoo
Tue, 08/16/16 - 11:14 am
ViiV Healthcare
HIV
Dolutegravir
HIV-1
lamivudine
ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV
Yahoo
Fri, 06/10/16 - 10:06 am
ViiV Healthcare
HIV
FDA
pediatric
Dolutegravir
Viiv Healthcare expands access to HIV drug through patent pooling
BioPharma Dive
Wed, 04/27/16 - 02:09 pm
ViiV Healthcare
HIV
patent pooling
Tivicay
Why ViiV Healthcare leads the pharma industry in corporate reputation
BioPharma Dive
Wed, 03/23/16 - 04:23 pm
ViiV Healthcare
Pfizer
GSK
Shionogi
AbbVie
Lundbeck
Janssen
Novo Nordisk
Bristol-Myers Squibb Completes Previously Announced Sale of its HIV R&D Portfolio to ViiV Healthcare
Yahoo
Mon, 02/22/16 - 09:55 pm
Bristol-Myers Squibb
HIV
ViiV Healthcare
GlaxoSmithKline On Path To Recovery
Bidness, ETC
Sun, 12/20/15 - 04:37 pm
GSK
ViiV Healthcare
Bristol-Myers Squibb
Glaxo to Pay Bristol-Myers Up to $1.46 Billion for HIV Drugs
Bloomberg
Fri, 12/18/15 - 08:45 am
GSK
Bristol-Myers Squibb
HIV
ViiV Healthcare
Johnson & Johnson HIV combination succeeds in mid-stage study
Yahoo/Reuters
Tue, 11/3/15 - 09:20 am
JNJ
HIV
cabotegravir
rilpivirine
ViiV Healthcare
GSK chief: We don't need a breakup or a Pfizer deal. Just look at ViiV's sales surge
Fierce Pharma
Wed, 10/28/15 - 03:14 pm
GSK
Pfizer
M&A
ViiV Healthcare
Andrew Witty
Here’s how GlaxoSmithKline Hopes To Trump Gilead Sciences In HIV Market
Bidness, ETC
Fri, 09/25/15 - 10:15 am
Gilead Sciences
GSK
HIV
ViiV Healthcare
ViiV Healthcare - The Hidden Gem Of GlaxoSmithKline's Balance Sheet
Seeking Alpha
Wed, 08/19/15 - 09:17 pm
GSK
ViiV Healthcare
Gilead
Pfizer
Bristol-Myers Squibb
HIV
Success at Glaxo's HIV Unit May Mean Having to Call It Quits
Yahoo/Bloomberg
Thu, 07/9/15 - 10:23 am
GSK
HIV
ViiV Healthcare
GlaxoSmithKline weighs an IPO for the HIV-focused ViiV as it sharpens the budget axe
Fierce Biotech
Wed, 10/22/14 - 08:32 am
GSK
ViiV Healthcare
IPOs
HIV
Pfizer

Pages